missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Imidazopyridines
  7. Serabelisib, MedChemExpress

Serabelisib, MedChemExpress

Product Code. 16481297
Encompass_Preferred
Change view
Click to view available options
Quantity:
5 mg
10 mg
25 mg
50 mg
100 mg
Unit Size:
100mg
10mg
25mg
50mg
5mg
5 product options available for selection
Product selection table with 5 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16481297 50 mg 50mg
16473286 25 mg 25mg
16447787 5 mg 5mg
16415068 10 mg 10mg
16405806 100 mg 100mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 5 options available.
5 options
This item is not returnable. View return policy
Product Code. 16481297 Supplier Medchem Express Supplier No. HY12285

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

MedChemExpress Serabelisib (MLN1117) is a selective p110α inhibitor with an IC50 of 15 nM.

Serabelisib (MLN1117) is a selective p110α inhibitor with an IC50 of 15 nM.

Specifications

Chemical Name or Material Serabelisib
CAS 1268454-23-4
Color Gray
Purity Grade Notes Research
Molecular Formula C19H17N5O3
Quantity 50 mg
Synonym MLN1117 INK1117 TAK-117
Solubility Information DMSO : 6.4 mg/mL (17.61 mM; Need ultrasonic and warming)
SMILES O=C(C1=CN=C2C=CC(C3=CC=C(OC(N)=N4)C4=C3)=CN21)N5CCOCC5
Molecular Weight (g/mol) 363.37
Formula Weight 363.37
Percent Purity 98.1%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.